Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review

(2015) Primož Strojan et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol

(2014) Katherine P. Morgan et al.   ANNALS OF PHARMACOTHERAPY

Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs)

(2013) Qing Li et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Role of CFTR in oxidative stress and suicidal death of renal cells during cisplatin-induced nephrotoxicity

(2013) I Rubera et al.   Cell Death & Disease

The Role of Mannitol as a Nephroprotectant in Patients Receiving Cisplatin Therapy

(2012) K. P. Morgan et al.   ANNALS OF PHARMACOTHERAPY

Comparison of Acute Toxicities in Two Primary Chemoradiation Regimens in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma

(2012) Katherine Y. Fan et al.   ANNALS OF SURGICAL ONCOLOGY

Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

(2012) Neife Aparecida Guinaim dos Santos et al.   ARCHIVES OF TOXICOLOGY

Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy

(2012) Paul B. Romesser et al.   CANCER

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

(2012) Jean Bourhis et al.   LANCET ONCOLOGY

Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer

(2011) V. Espeli et al.   ORAL ONCOLOGY

Intra-arterial chemotherapy for head and neck cancer

(2010) Coen R. N. Rasch et al.   CANCER

Comparison of Four Cisplatin-Based Radiochemotherapy Regimens for Nonmetastatic Stage III/IV Squamous Cell Carcinoma of the Head and Neck

(2010) Dirk Rades et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer

(2007) Dirk Rades et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK